SRT1720 inhibits bladder cancer growth in organoids and murine models through the SIRT1/HIF axis.[38] The detailed mechanisms underlying the inhibitory and radio‐sensitization effects of SRT1720 on the SULT1E1+ subpopulation remain unclear and warrant further research. Here, SIRT1 is linked to urinary bladder cancer.